FDA Brief

Company record

Wells Pharma of Houston, LLC

1 FDA warning letter since 2023 and 7 recalls in the last 12 months.

Get an email the day FDA posts anything new about Wells Pharma of Houston, LLC.

Warning letters

  1. Wells Pharma of Houston, LLC

    Compounding Pharmacy/Adulterated Drug Products

Recalls

ReportedClassFirmProduct and reason
May 6 Class II Wells Pharma of Houston LLC
Drug
Ketamine Hydrochloride Injectable Solution, 50mg/ml, (50 mg per mL) Volume: 1 mL, 5265 Kitty Drive, Houston, TX 77054, NDC 73702-302-31.
cGMP deviations.
May 6 Class II Wells Pharma of Houston LLC
Drug
fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 1000 mcg/50mL (20 mcg per mL), well pharma of Houston, NDC 73702-203-65.
cGMP deviations.
May 6 Class II Wells Pharma of Houston LLC
Drug
fentaNYL Citrate injectable Solution in 0.9% Sodium Chloride, Narcotic, (2500 mcg/ 250 mL) (10 mcg per mL), 250 mL bag, wells pharma of Houston, NDC 73702-202-03.
cGMP deviations.
May 6 Class II Wells Pharma of Houston LLC
Drug
fentaNYL Citrate Injectable Solution, NARCOTIC, Cii, 1000 mcg/100 mL (10 mcg per mL), 100 mL bag, Wells Pharma in Houston, NDC 73702-202-02.
cGMP deviations.
May 6 Class II Wells Pharma of Houston LLC
Drug
fentaNYL Citrate Injectable Solution, Narcotic, CII, 1250 mcg/25mL (50 mcg per mL), 25 mL, wells pharma of Houston, NDC 73702-204-25.
cGMP deviations.
May 6 Class II Wells Pharma of Houston LLC
Drug
Phenylephrine Hydrochloride Injectable Solution, 40mg, 250*mL Bag, wells pharma of Houston, NDC 73702-122-03
cGMP deviations.
May 6 Class II Wells Pharma of Houston LLC
Drug
fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15.
cGMP deviations.